News | December 07, 2022
Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Man lost 54 Kgs in 6 months with MGB procedure
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
To address the preventive & primary healthcare delivery gaps in India
Subscribe To Our Newsletter & Stay Updated
